Allarity Therapeutics Inc (NASDAQ:ALLR) has a beta value of -0.01 and has seen 5.15 million shares traded in the last trading session. The company, currently valued at $4.97M, closed the last trade at $1.12 per share which meant it gained $0.06 on the day or 5.66% during that session. The ALLR stock price is -22292.86% off its 52-week high price of $250.80 and 39.29% above the 52-week low of $0.68.
The consensus among analysts is that Allarity Therapeutics Inc (ALLR) is Buy stock at the moment, with a recommendation rating of 1.00. 0 analysts rate the stock as a Sell, while 0 rate it as Overweight. 0 out of 1 have rated it as a Hold, with 1 advising it as a Buy. 0 have rated the stock as Underweight. The expected earnings per share for the stock is 0.
Allarity Therapeutics Inc (NASDAQ:ALLR) trade information
Sporting 5.66% in the green in last session, the stock has traded in the green over the last five days, with the highest price hit on recent trading when the ALLR stock price touched $1.12 or saw a rise of 9.68%. Year-to-date, Allarity Therapeutics Inc shares have moved -4.27%, while the 5-day performance has seen it change 27.26%. Over the past 30 days, the shares of Allarity Therapeutics Inc (NASDAQ:ALLR) have changed 7.69%.
Allarity Therapeutics Inc (ALLR) estimates and forecasts
The company’s shares have lost -77.59% over the past 6 months.
If we evaluate the company’s growth over the last 5-year and for the next 5-year period, we find that annual earnings growth was 57.56% over the past 5 years.
ALLR Dividends
Allarity Therapeutics Inc is expected to release its next earnings report in April this year, and investors are excited at the prospect of better dividends despite the company’s debt issue.
Also the top two Mutual Funds that are holding company’s shares are Fidelity Extended Market Index Fund and Fidelity Series Total Market Index Fund . As of Dec 31, 2024 , the former fund manager holds about 0.16% shares in the company for having 7.19 shares of worth $8055.0 while later fund manager owns 1.93 shares of worth $2166.0 as of Dec 31, 2024 , which makes it owner of about 0.04% of company’s outstanding stock.
